Literature DB >> 35930364

Hydrogel dressings for venous leg ulcers.

Cibele Td Ribeiro1, Fernando Al Dias2, Guilherme Af Fregonezi3.   

Abstract

BACKGROUND: Venous leg ulcers are a chronic health problem that cause considerable economic impact and affect quality of life for those who have them. Primary wound contact dressings are usually applied to ulcers beneath compression therapy to aid healing, promote comfort and control exudate. There are numerous dressing products available for venous leg ulcers and hydrogel is often prescribed for this condition; however, the evidence base to guide dressing choice is sparse.
OBJECTIVES: To assess the effects of hydrogel wound dressings on the healing of venous leg ulcers in any care setting. SEARCH
METHODS: In May 2021, we searched the Cochrane Wounds Specialised Register, CENTRAL, Ovid MEDLINE, Ovid Embase and EBSCO CINAHL Plus. We also searched clinical trials registries for ongoing and unpublished studies, and scanned reference lists of relevant included studies, reviews, meta-analyses and health technology reports to identify additional studies. There were no restrictions with respect to language, date of publication or study setting. SELECTION CRITERIA: We included randomised controlled trials (RCTs), either published or unpublished, that compared the effects of hydrogel dressing with other dressings on the healing of venous leg ulcers. We excluded trials evaluating hydrogel dressings impregnated with antimicrobial, antiseptic or analgesic agents as these interventions are evaluated in other Cochrane Reviews. DATA COLLECTION AND ANALYSIS: We used standard methodological procedures expected by Cochrane. We assessed the certainty of the evidence using the GRADE approach. MAIN
RESULTS: We included four RCTs (10 articles) in a qualitative analysis. Overall, 272 participants were randomised, in sample sizes ranging from 20 to 156 participants. The mean age of the included population in the trials ranged from 55 to 68 years, 37% were women based on studies that reported the sex of participants. The studies compared hydrogel dressings with the following: gauze and saline, alginate dressing, manuka honey and hydrocolloid. Two studies were multicentre and the others were single-centre trials. Length of treatment using hydrogel dressing was four weeks in three studies and two weeks in one study. The follow-up period was the same as the duration of treatment in three studies and in one study the follow-up for wound healing was at 12 weeks after four weeks of treatment. Overall risk of bias was high for all trials because at least one of the three key criteria (selection bias, detection bias and attrition bias) was at high risk. Hydrogel compared with gauze and saline It is uncertain whether there is a difference in complete wound healing (risk ratio (RR) 5.33, 95% confidence interval (CI) 1.73 to 16.42; 1 trial, 60 participants) or change in ulcer size (mean difference (MD) -1.50, 95% CI -1.86 to -1.14; 1 trial, 60 participants) between interventions because the certainty of the evidence is very low. Data reported from one trial were incomplete for time-to-ulcer healing. Hydrogel compared with alginate dressing It is uncertain whether there is a difference in change in ulcer size between hydrogel and alginate gel because the certainty of the evidence is very low (MD -41.80, 95% CI -63.95 to -19.65; 1 trial, 20 participants). Hydrogel compared with manuka honey It is uncertain whether there is a difference in complete wound healing (RR 0.75, 95% CI 0.46 to 1.21; 1 trial, 108 participants) or incidence of wound infection (RR 2.00, 95% CI 0.81 to 4.94; 1 trial, 108 participants) between interventions because the certainty of the evidence is very low. Hydrogel compared with hydrocolloid One study (84 participants) reported on change in ulcer size between hydrogel and hydrocolloid; however, further analysis was not possible because authors did not report standard errors or any other measurement of variance of a set of data from the means. Therefore, it is also uncertain whether there is a difference in change in ulcer size between hydrogel and hydrocolloid because the certainty of the evidence is very low. No studies provided evidence for the outcomes: recurrence of ulcer, health-related quality of life, pain and costs. Overall, independent of the comparison, the certainty of evidence is very low and downgraded twice due to risk of bias and once or twice due to imprecision for all comparisons and outcomes. AUTHORS'
CONCLUSIONS: There is inconclusive evidence to determine the effectiveness of hydrogel dressings compared with gauze and saline, alginate dressing, manuka honey or hydrocolloid on venous leg ulcer healing. Practitioners may, therefore, consider other characteristics such as costs and symptom management when choosing between dressings. Any future studies assessing the effects of hydrogel on venous wound healing should consider using all the steps from CONSORT, and consider key points such as appropriate sample size with the power to detect expected differences, appropriate outcomes (such as time-to-event analysis) and adverse effects. If time-to-event analysis is not used, at least a longer follow-up (e.g. 12 weeks and above) should be adopted. Future studies should also address important outcomes that the studies we included did not investigate, such as health-related quality of life, pain and wound recurrence.
Copyright © 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35930364      PMCID: PMC9354941          DOI: 10.1002/14651858.CD010738.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  45 in total

1.  Retraction statement: Manuka honey vs. hydrogel - a prospective, open label, multicentre, randomised controlled trial to compare desloughing efficacy and healing outcomes in venous ulcers.

Authors: 
Journal:  J Clin Nurs       Date:  2014-07-02       Impact factor: 3.036

Review 2.  Treating the chronic wound: A practical approach to the care of nonhealing wounds and wound care dressings.

Authors:  Margaret A Fonder; Gerald S Lazarus; David A Cowan; Barbara Aronson-Cook; Angela R Kohli; Adam J Mamelak
Journal:  J Am Acad Dermatol       Date:  2008-02       Impact factor: 11.527

3.  Manuka honey improved wound healing in patients with sloughy venous leg ulcers.

Authors:  David G Armstrong
Journal:  Evid Based Med       Date:  2009-10

4.  Diagnosis and treatment of venous ulcers.

Authors:  Lauren Collins; Samina Seraj
Journal:  Am Fam Physician       Date:  2010-04-15       Impact factor: 3.292

5.  Processes underlying adherence to leg ulcer treatment: a qualitative field study.

Authors:  Ann Van Hecke; Sofie Verhaeghe; Maria Grypdonck; Hilde Beele; Tom Defloor
Journal:  Int J Nurs Stud       Date:  2010-08-07       Impact factor: 5.837

6.  The influence of patient and wound variables on healing of venous leg ulcers in a randomized controlled trial of growth-arrested allogeneic keratinocytes and fibroblasts.

Authors:  John C Lantis; William A Marston; Alik Farber; Robert S Kirsner; Yuxin Zhang; Tommy D Lee; D Innes Cargill; Herbert B Slade
Journal:  J Vasc Surg       Date:  2013-04-12       Impact factor: 4.268

Review 7.  Leg ulcers: a review of their impact on daily life.

Authors:  Anke Persoon; Maud M Heinen; Carien J M van der Vleuten; Michette J de Rooij; Peter C M van de Kerkhof; Theo van Achterberg
Journal:  J Clin Nurs       Date:  2004-03       Impact factor: 3.036

Review 8.  Antibiotics and antiseptics for venous leg ulcers.

Authors:  Susan O'Meara; Deyaa Al-Kurdi; Yemisi Ologun; Liza G Ovington
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 9.  Skin grafting for venous leg ulcers.

Authors:  J E Jones; E A Nelson
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

Review 10.  2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery.

Authors:  Thom W Rooke; Alan T Hirsch; Sanjay Misra; Anton N Sidawy; Joshua A Beckman; Laura K Findeiss; Jafar Golzarian; Heather L Gornik; Jonathan L Halperin; Michael R Jaff; Gregory L Moneta; Jeffrey W Olin; James C Stanley; Christopher J White; John V White; R Eugene Zierler
Journal:  J Vasc Surg       Date:  2011-09-29       Impact factor: 4.268

View more
  4 in total

Review 1.  Hydrogel dressings for venous leg ulcers.

Authors:  Cibele Td Ribeiro; Fernando Al Dias; Guilherme Af Fregonezi
Journal:  Cochrane Database Syst Rev       Date:  2022-08-05

Review 2.  Alginate dressings for venous leg ulcers.

Authors:  Susan O'Meara; Marrissa Martyn-St James; Una J Adderley
Journal:  Cochrane Database Syst Rev       Date:  2015-08-19

3.  Dressings and topical agents for arterial leg ulcers.

Authors:  Cathryn Broderick; Fania Pagnamenta; Rachel Forster
Journal:  Cochrane Database Syst Rev       Date:  2020-01-20

Review 4.  Dressings and topical agents for treating venous leg ulcers.

Authors:  Gill Norman; Maggie J Westby; Amber D Rithalia; Nikki Stubbs; Marta O Soares; Jo C Dumville
Journal:  Cochrane Database Syst Rev       Date:  2018-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.